These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner]. Ypenburg C; Verwey HF; van der Wall EE Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2426-8. PubMed ID: 18064859 [TBL] [Abstract][Full Text] [Related]
27. Rationale and design of the enoximone clinical trials program. Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960 [TBL] [Abstract][Full Text] [Related]
28. Nesiritide for decompensated congestive heart failure. Med Lett Drugs Ther; 2001 Nov; 43(1118):100-1. PubMed ID: 11707752 [No Abstract] [Full Text] [Related]
29. New positive inotropic agents in the treatment of left ventricular dysfunction. De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917 [TBL] [Abstract][Full Text] [Related]
31. The cul-de-sac at the end of the road. Stevenson LW J Card Fail; 2003 Jun; 9(3):188-91. PubMed ID: 12815568 [No Abstract] [Full Text] [Related]
32. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes. Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759 [TBL] [Abstract][Full Text] [Related]
33. [Risk factors for dying among ibopamine users]. Vandenbroucke JP Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378 [No Abstract] [Full Text] [Related]
34. [Therapy of ischemic and nonischemic heart failure. Current status and prospects]. Weil J; Riegger G Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003 [No Abstract] [Full Text] [Related]
35. Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure. Young JB J Am Coll Cardiol; 2005 Aug; 46(3):505-7. PubMed ID: 16053965 [No Abstract] [Full Text] [Related]
36. The flosequinan experience and its implications. Hingorani AD Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):683; author reply 683-4. PubMed ID: 8124556 [No Abstract] [Full Text] [Related]
37. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN; J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178 [TBL] [Abstract][Full Text] [Related]
38. [Why are results of studies with digitalis so poor? "It depends on potassium!"]. Hien M MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934 [No Abstract] [Full Text] [Related]
39. Just the berries. Management of heart failure. Ruggles L Can Fam Physician; 2001 Mar; 47():499-501. PubMed ID: 11281082 [No Abstract] [Full Text] [Related]
40. Vesnarinone for heart failure. Schwartz A; Grupp I; Grupp G N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]